nodes	percent_of_prediction	percent_of_DWPC	metapath
Cladribine—NR5A1—corpus luteum—hypothyroidism	0.0734	0.141	CbGeAlD
Cladribine—NR5A1—seminiferous tubule of testis—hypothyroidism	0.0622	0.12	CbGeAlD
Cladribine—PNP—tongue—hypothyroidism	0.019	0.0367	CbGeAlD
Cladribine—NR5A1—Nuclear Receptors—THRA—hypothyroidism	0.019	0.131	CbGpPWpGaD
Cladribine—NR5A1—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.015	0.103	CbGpPWpGaD
Cladribine—Phlebitis—Liothyronine—hypothyroidism	0.0134	0.0398	CcSEcCtD
Cladribine—NR5A1—Nuclear Receptors—THRB—hypothyroidism	0.0122	0.0842	CbGpPWpGaD
Cladribine—NR5A1—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.00966	0.0665	CbGpPWpGaD
Cladribine—POLE2—adrenal gland—hypothyroidism	0.00854	0.0164	CbGeAlD
Cladribine—POLE2—blood—hypothyroidism	0.00853	0.0164	CbGeAlD
Cladribine—POLE2—female gonad—hypothyroidism	0.00796	0.0153	CbGeAlD
Cladribine—POLE4—liver—hypothyroidism	0.00764	0.0147	CbGeAlD
Cladribine—Wheezing—Dextrothyroxine—hypothyroidism	0.00757	0.0225	CcSEcCtD
Cladribine—Wheezing—Levothyroxine—hypothyroidism	0.00757	0.0225	CcSEcCtD
Cladribine—Arrhythmia—Liothyronine—hypothyroidism	0.00712	0.0212	CcSEcCtD
Cladribine—POLE2—testis—hypothyroidism	0.00706	0.0136	CbGeAlD
Cladribine—RRM2B—adrenal cortex—hypothyroidism	0.00694	0.0134	CbGeAlD
Cladribine—RRM2B—heart—hypothyroidism	0.00671	0.0129	CbGeAlD
Cladribine—POLE2—liver—hypothyroidism	0.00667	0.0129	CbGeAlD
Cladribine—Extravasation—Liotrix—hypothyroidism	0.00657	0.0196	CcSEcCtD
Cladribine—POLE3—adrenal cortex—hypothyroidism	0.00656	0.0126	CbGeAlD
Cladribine—NR5A1—adrenal cortex—hypothyroidism	0.00636	0.0123	CbGeAlD
Cladribine—POLE3—heart—hypothyroidism	0.00635	0.0122	CbGeAlD
Cladribine—Disorientation—Levothyroxine—hypothyroidism	0.00632	0.0188	CcSEcCtD
Cladribine—Disorientation—Dextrothyroxine—hypothyroidism	0.00632	0.0188	CcSEcCtD
Cladribine—Cellulitis—Liotrix—hypothyroidism	0.0063	0.0188	CcSEcCtD
Cladribine—POLE3—cardiovascular system—hypothyroidism	0.00599	0.0115	CbGeAlD
Cladribine—Cardiac failure—Dextrothyroxine—hypothyroidism	0.0058	0.0173	CcSEcCtD
Cladribine—Cardiac failure—Levothyroxine—hypothyroidism	0.0058	0.0173	CcSEcCtD
Cladribine—RRM2B—pituitary gland—hypothyroidism	0.00561	0.0108	CbGeAlD
Cladribine—Wheezing—Liotrix—hypothyroidism	0.00557	0.0166	CcSEcCtD
Cladribine—Tachycardia—Liothyronine—hypothyroidism	0.00553	0.0165	CcSEcCtD
Cladribine—POLE3—gonad—hypothyroidism	0.00544	0.0105	CbGeAlD
Cladribine—PNP—blood—hypothyroidism	0.0054	0.0104	CbGeAlD
Cladribine—POLE3—pituitary gland—hypothyroidism	0.0053	0.0102	CbGeAlD
Cladribine—Hypotension—Liothyronine—hypothyroidism	0.00529	0.0158	CcSEcCtD
Cladribine—NR5A1—gonad—hypothyroidism	0.00527	0.0101	CbGeAlD
Cladribine—NR5A1—pituitary gland—hypothyroidism	0.00514	0.0099	CbGeAlD
Cladribine—PNP—female gonad—hypothyroidism	0.00503	0.0097	CbGeAlD
Cladribine—RRM2B—adrenal gland—hypothyroidism	0.00501	0.00966	CbGeAlD
Cladribine—RRM2B—blood—hypothyroidism	0.00501	0.00965	CbGeAlD
Cladribine—Muscular weakness—Dextrothyroxine—hypothyroidism	0.00499	0.0149	CcSEcCtD
Cladribine—Muscular weakness—Levothyroxine—hypothyroidism	0.00499	0.0149	CcSEcCtD
Cladribine—Sepsis—Liotrix—hypothyroidism	0.00498	0.0148	CcSEcCtD
Cladribine—POLE—heart—hypothyroidism	0.00484	0.00933	CbGeAlD
Cladribine—RRM2B—thyroid gland—hypothyroidism	0.00484	0.00932	CbGeAlD
Cladribine—Phlebitis—Liotrix—hypothyroidism	0.00483	0.0144	CcSEcCtD
Cladribine—Sweating increased—Levothyroxine—hypothyroidism	0.00476	0.0142	CcSEcCtD
Cladribine—Sweating increased—Dextrothyroxine—hypothyroidism	0.00476	0.0142	CcSEcCtD
Cladribine—POLE3—adrenal gland—hypothyroidism	0.00474	0.00913	CbGeAlD
Cladribine—POLE3—blood—hypothyroidism	0.00474	0.00913	CbGeAlD
Cladribine—Swelling—Liotrix—hypothyroidism	0.00472	0.0141	CcSEcCtD
Cladribine—RRM2B—female gonad—hypothyroidism	0.00467	0.009	CbGeAlD
Cladribine—Disorientation—Liotrix—hypothyroidism	0.00465	0.0139	CcSEcCtD
Cladribine—SLC28A3—Transport of vitamins, nucleosides, and related molecules—AVP—hypothyroidism	0.00461	0.0318	CbGpPWpGaD
Cladribine—NR5A1—adrenal gland—hypothyroidism	0.00459	0.00884	CbGeAlD
Cladribine—POLE3—thyroid gland—hypothyroidism	0.00457	0.00881	CbGeAlD
Cladribine—Renal failure acute—Liotrix—hypothyroidism	0.00451	0.0134	CcSEcCtD
Cladribine—Body temperature increased—Liothyronine—hypothyroidism	0.00448	0.0133	CcSEcCtD
Cladribine—POLE3—female gonad—hypothyroidism	0.00442	0.00851	CbGeAlD
Cladribine—SLC22A2—Amine compound SLC transporters—SLC5A7—hypothyroidism	0.0044	0.0303	CbGpPWpGaD
Cladribine—Renal impairment—Liotrix—hypothyroidism	0.00437	0.013	CcSEcCtD
Cladribine—NR5A1—female gonad—hypothyroidism	0.00428	0.00825	CbGeAlD
Cladribine—Cardiac failure—Liotrix—hypothyroidism	0.00426	0.0127	CcSEcCtD
Cladribine—Cerebrovascular accident—Liotrix—hypothyroidism	0.00425	0.0127	CcSEcCtD
Cladribine—PNP—liver—hypothyroidism	0.00422	0.00813	CbGeAlD
Cladribine—POLA1—heart—hypothyroidism	0.00417	0.00804	CbGeAlD
Cladribine—POLE—gonad—hypothyroidism	0.00415	0.00799	CbGeAlD
Cladribine—RRM2B—testis—hypothyroidism	0.00414	0.00799	CbGeAlD
Cladribine—SLC28A3—female gonad—hypothyroidism	0.00413	0.00796	CbGeAlD
Cladribine—SLC22A1—Amine compound SLC transporters—SLC5A7—hypothyroidism	0.0041	0.0283	CbGpPWpGaD
Cladribine—POLE—pituitary gland—hypothyroidism	0.00405	0.00779	CbGeAlD
Cladribine—NR5A1—Generic Transcription Pathway—ZNF764—hypothyroidism	0.00402	0.0277	CbGpPWpGaD
Cladribine—RRM2B—liver—hypothyroidism	0.00392	0.00755	CbGeAlD
Cladribine—POLE3—testis—hypothyroidism	0.00392	0.00755	CbGeAlD
Cladribine—RRM2B—cerebellum—hypothyroidism	0.00383	0.00737	CbGeAlD
Cladribine—NR5A1—testis—hypothyroidism	0.0038	0.00731	CbGeAlD
Cladribine—RRM2—cardiovascular system—hypothyroidism	0.00376	0.00725	CbGeAlD
Cladribine—POLE3—liver—hypothyroidism	0.0037	0.00714	CbGeAlD
Cladribine—Muscular weakness—Liotrix—hypothyroidism	0.00367	0.0109	CcSEcCtD
Cladribine—POLE3—cerebellum—hypothyroidism	0.00362	0.00697	CbGeAlD
Cladribine—POLE—adrenal gland—hypothyroidism	0.00361	0.00696	CbGeAlD
Cladribine—POLE—blood—hypothyroidism	0.00361	0.00696	CbGeAlD
Cladribine—NR5A1—cerebellum—hypothyroidism	0.00351	0.00676	CbGeAlD
Cladribine—Sweating increased—Liotrix—hypothyroidism	0.0035	0.0104	CcSEcCtD
Cladribine—Arrhythmia—Dextrothyroxine—hypothyroidism	0.0035	0.0104	CcSEcCtD
Cladribine—Arrhythmia—Levothyroxine—hypothyroidism	0.0035	0.0104	CcSEcCtD
Cladribine—POLE—thyroid gland—hypothyroidism	0.00349	0.00672	CbGeAlD
Cladribine—POLA1—pituitary gland—hypothyroidism	0.00349	0.00672	CbGeAlD
Cladribine—Alopecia—Dextrothyroxine—hypothyroidism	0.00346	0.0103	CcSEcCtD
Cladribine—Alopecia—Levothyroxine—hypothyroidism	0.00346	0.0103	CcSEcCtD
Cladribine—RRM1—adrenal cortex—hypothyroidism	0.00343	0.0066	CbGeAlD
Cladribine—RRM2—gonad—hypothyroidism	0.00342	0.00658	CbGeAlD
Cladribine—POLE—female gonad—hypothyroidism	0.00337	0.00649	CbGeAlD
Cladribine—SLC22A2—Neurotransmitter Release Cycle—SLC5A7—hypothyroidism	0.00336	0.0232	CbGpPWpGaD
Cladribine—RRM2—pituitary gland—hypothyroidism	0.00333	0.00642	CbGeAlD
Cladribine—RRM1—heart—hypothyroidism	0.00331	0.00638	CbGeAlD
Cladribine—Renal failure—Liotrix—hypothyroidism	0.00315	0.00939	CcSEcCtD
Cladribine—SLC28A3—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.00315	0.0217	CbGpPWpGaD
Cladribine—SLC22A1—Neurotransmitter Release Cycle—SLC5A7—hypothyroidism	0.00313	0.0216	CbGpPWpGaD
Cladribine—RRM1—cardiovascular system—hypothyroidism	0.00313	0.00602	CbGeAlD
Cladribine—POLA1—adrenal gland—hypothyroidism	0.00312	0.006	CbGeAlD
Cladribine—POLA1—blood—hypothyroidism	0.00311	0.006	CbGeAlD
Cladribine—POLA1—thyroid gland—hypothyroidism	0.00301	0.00579	CbGeAlD
Cladribine—POLE—testis—hypothyroidism	0.00299	0.00576	CbGeAlD
Cladribine—RRM2—adrenal gland—hypothyroidism	0.00298	0.00573	CbGeAlD
Cladribine—RRM2—blood—hypothyroidism	0.00298	0.00573	CbGeAlD
Cladribine—POLA1—female gonad—hypothyroidism	0.0029	0.0056	CbGeAlD
Cladribine—Arthralgia—Levothyroxine—hypothyroidism	0.0029	0.00864	CcSEcCtD
Cladribine—Arthralgia—Dextrothyroxine—hypothyroidism	0.0029	0.00864	CcSEcCtD
Cladribine—Anxiety—Dextrothyroxine—hypothyroidism	0.00289	0.00861	CcSEcCtD
Cladribine—Anxiety—Levothyroxine—hypothyroidism	0.00289	0.00861	CcSEcCtD
Cladribine—RRM2—thyroid gland—hypothyroidism	0.00287	0.00553	CbGeAlD
Cladribine—RRM1—gonad—hypothyroidism	0.00284	0.00547	CbGeAlD
Cladribine—POLE—liver—hypothyroidism	0.00283	0.00544	CbGeAlD
Cladribine—Confusional state—Dextrothyroxine—hypothyroidism	0.0028	0.00835	CcSEcCtD
Cladribine—Confusional state—Levothyroxine—hypothyroidism	0.0028	0.00835	CcSEcCtD
Cladribine—RRM2—female gonad—hypothyroidism	0.00278	0.00535	CbGeAlD
Cladribine—RRM1—pituitary gland—hypothyroidism	0.00277	0.00533	CbGeAlD
Cladribine—POLE—cerebellum—hypothyroidism	0.00276	0.00532	CbGeAlD
Cladribine—Tachycardia—Dextrothyroxine—hypothyroidism	0.00271	0.00808	CcSEcCtD
Cladribine—Tachycardia—Levothyroxine—hypothyroidism	0.00271	0.00808	CcSEcCtD
Cladribine—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00269	0.00801	CcSEcCtD
Cladribine—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00269	0.00801	CcSEcCtD
Cladribine—DCK—adrenal cortex—hypothyroidism	0.00266	0.00513	CbGeAlD
Cladribine—SLC28A3—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.00261	0.018	CbGpPWpGaD
Cladribine—NR5A1—Generic Transcription Pathway—THRA—hypothyroidism	0.00259	0.0178	CbGpPWpGaD
Cladribine—POLA1—testis—hypothyroidism	0.00258	0.00496	CbGeAlD
Cladribine—DCK—heart—hypothyroidism	0.00257	0.00496	CbGeAlD
Cladribine—Arrhythmia—Liotrix—hypothyroidism	0.00257	0.00766	CcSEcCtD
Cladribine—Alopecia—Liotrix—hypothyroidism	0.00254	0.00758	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00253	0.00755	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00253	0.00755	CcSEcCtD
Cladribine—Insomnia—Dextrothyroxine—hypothyroidism	0.00252	0.00749	CcSEcCtD
Cladribine—Insomnia—Levothyroxine—hypothyroidism	0.00252	0.00749	CcSEcCtD
Cladribine—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00248	0.00738	CcSEcCtD
Cladribine—Dyspnoea—Levothyroxine—hypothyroidism	0.00248	0.00738	CcSEcCtD
Cladribine—RRM1—adrenal gland—hypothyroidism	0.00247	0.00476	CbGeAlD
Cladribine—RRM1—blood—hypothyroidism	0.00247	0.00476	CbGeAlD
Cladribine—Flatulence—Liotrix—hypothyroidism	0.00247	0.00736	CcSEcCtD
Cladribine—RRM2—testis—hypothyroidism	0.00246	0.00474	CbGeAlD
Cladribine—POLA1—liver—hypothyroidism	0.00244	0.00469	CbGeAlD
Cladribine—Fatigue—Levothyroxine—hypothyroidism	0.0024	0.00714	CcSEcCtD
Cladribine—Fatigue—Dextrothyroxine—hypothyroidism	0.0024	0.00714	CcSEcCtD
Cladribine—RRM1—thyroid gland—hypothyroidism	0.00239	0.0046	CbGeAlD
Cladribine—POLA1—cerebellum—hypothyroidism	0.00238	0.00458	CbGeAlD
Cladribine—RRM2—liver—hypothyroidism	0.00233	0.00448	CbGeAlD
Cladribine—RRM1—female gonad—hypothyroidism	0.00231	0.00444	CbGeAlD
Cladribine—Feeling abnormal—Levothyroxine—hypothyroidism	0.00229	0.00683	CcSEcCtD
Cladribine—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00229	0.00683	CcSEcCtD
Cladribine—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00227	0.00677	CcSEcCtD
Cladribine—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00227	0.00677	CcSEcCtD
Cladribine—Urticaria—Dextrothyroxine—hypothyroidism	0.00221	0.00658	CcSEcCtD
Cladribine—Urticaria—Levothyroxine—hypothyroidism	0.00221	0.00658	CcSEcCtD
Cladribine—DCK—gonad—hypothyroidism	0.0022	0.00425	CbGeAlD
Cladribine—Body temperature increased—Dextrothyroxine—hypothyroidism	0.0022	0.00655	CcSEcCtD
Cladribine—Abdominal pain—Dextrothyroxine—hypothyroidism	0.0022	0.00655	CcSEcCtD
Cladribine—Abdominal pain—Levothyroxine—hypothyroidism	0.0022	0.00655	CcSEcCtD
Cladribine—Body temperature increased—Levothyroxine—hypothyroidism	0.0022	0.00655	CcSEcCtD
Cladribine—DCK—pituitary gland—hypothyroidism	0.00215	0.00414	CbGeAlD
Cladribine—Arthralgia—Liotrix—hypothyroidism	0.00213	0.00636	CcSEcCtD
Cladribine—Chest pain—Liotrix—hypothyroidism	0.00213	0.00636	CcSEcCtD
Cladribine—Anxiety—Liotrix—hypothyroidism	0.00213	0.00633	CcSEcCtD
Cladribine—Confusional state—Liotrix—hypothyroidism	0.00206	0.00614	CcSEcCtD
Cladribine—Oedema—Liotrix—hypothyroidism	0.00205	0.00609	CcSEcCtD
Cladribine—RRM1—testis—hypothyroidism	0.00204	0.00394	CbGeAlD
Cladribine—Infection—Liotrix—hypothyroidism	0.00203	0.00605	CcSEcCtD
Cladribine—Tachycardia—Liotrix—hypothyroidism	0.002	0.00595	CcSEcCtD
Cladribine—Asthenia—Dextrothyroxine—hypothyroidism	0.002	0.00594	CcSEcCtD
Cladribine—Asthenia—Levothyroxine—hypothyroidism	0.002	0.00594	CcSEcCtD
Cladribine—Hyperhidrosis—Liotrix—hypothyroidism	0.00198	0.00589	CcSEcCtD
Cladribine—Pruritus—Levothyroxine—hypothyroidism	0.00197	0.00586	CcSEcCtD
Cladribine—Pruritus—Dextrothyroxine—hypothyroidism	0.00197	0.00586	CcSEcCtD
Cladribine—Anorexia—Liotrix—hypothyroidism	0.00195	0.00581	CcSEcCtD
Cladribine—NR5A1—Gene Expression—ZNF764—hypothyroidism	0.00194	0.0133	CbGpPWpGaD
Cladribine—RRM1—liver—hypothyroidism	0.00193	0.00372	CbGeAlD
Cladribine—DCK—adrenal gland—hypothyroidism	0.00192	0.0037	CbGeAlD
Cladribine—DCK—blood—hypothyroidism	0.00192	0.0037	CbGeAlD
Cladribine—Hypotension—Liotrix—hypothyroidism	0.00191	0.00569	CcSEcCtD
Cladribine—Diarrhoea—Dextrothyroxine—hypothyroidism	0.0019	0.00567	CcSEcCtD
Cladribine—Diarrhoea—Levothyroxine—hypothyroidism	0.0019	0.00567	CcSEcCtD
Cladribine—RRM1—cerebellum—hypothyroidism	0.00189	0.00364	CbGeAlD
Cladribine—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.00186	0.00555	CcSEcCtD
Cladribine—DCK—thyroid gland—hypothyroidism	0.00185	0.00357	CbGeAlD
Cladribine—Insomnia—Liotrix—hypothyroidism	0.00185	0.00551	CcSEcCtD
Cladribine—NR5A1—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.00185	0.0127	CbGpPWpGaD
Cladribine—Paraesthesia—Liotrix—hypothyroidism	0.00184	0.00547	CcSEcCtD
Cladribine—Dyspnoea—Liotrix—hypothyroidism	0.00182	0.00543	CcSEcCtD
Cladribine—DCK—female gonad—hypothyroidism	0.00179	0.00345	CbGeAlD
Cladribine—Decreased appetite—Liotrix—hypothyroidism	0.00178	0.0053	CcSEcCtD
Cladribine—RRM2B—Metabolism—IYD—hypothyroidism	0.00177	0.0122	CbGpPWpGaD
Cladribine—Vomiting—Levothyroxine—hypothyroidism	0.00177	0.00527	CcSEcCtD
Cladribine—Vomiting—Dextrothyroxine—hypothyroidism	0.00177	0.00527	CcSEcCtD
Cladribine—Fatigue—Liotrix—hypothyroidism	0.00176	0.00525	CcSEcCtD
Cladribine—Rash—Dextrothyroxine—hypothyroidism	0.00175	0.00522	CcSEcCtD
Cladribine—Rash—Levothyroxine—hypothyroidism	0.00175	0.00522	CcSEcCtD
Cladribine—Dermatitis—Dextrothyroxine—hypothyroidism	0.00175	0.00522	CcSEcCtD
Cladribine—Dermatitis—Levothyroxine—hypothyroidism	0.00175	0.00522	CcSEcCtD
Cladribine—Constipation—Liotrix—hypothyroidism	0.00175	0.00521	CcSEcCtD
Cladribine—Headache—Levothyroxine—hypothyroidism	0.00174	0.00519	CcSEcCtD
Cladribine—Headache—Dextrothyroxine—hypothyroidism	0.00174	0.00519	CcSEcCtD
Cladribine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.00172	0.0119	CbGpPWpGaD
Cladribine—Feeling abnormal—Liotrix—hypothyroidism	0.00169	0.00502	CcSEcCtD
Cladribine—Gastrointestinal pain—Liotrix—hypothyroidism	0.00167	0.00498	CcSEcCtD
Cladribine—NR5A1—Generic Transcription Pathway—THRB—hypothyroidism	0.00167	0.0115	CbGpPWpGaD
Cladribine—Nausea—Dextrothyroxine—hypothyroidism	0.00165	0.00492	CcSEcCtD
Cladribine—Nausea—Levothyroxine—hypothyroidism	0.00165	0.00492	CcSEcCtD
Cladribine—SLC22A1—blood—hypothyroidism	0.00164	0.00316	CbGeAlD
Cladribine—Urticaria—Liotrix—hypothyroidism	0.00163	0.00484	CcSEcCtD
Cladribine—Abdominal pain—Liotrix—hypothyroidism	0.00162	0.00482	CcSEcCtD
Cladribine—Body temperature increased—Liotrix—hypothyroidism	0.00162	0.00482	CcSEcCtD
Cladribine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.0016	0.011	CbGpPWpGaD
Cladribine—SLC28A3—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.0016	0.011	CbGpPWpGaD
Cladribine—DCK—testis—hypothyroidism	0.00159	0.00306	CbGeAlD
Cladribine—PNP—Metabolism—IYD—hypothyroidism	0.00153	0.0106	CbGpPWpGaD
Cladribine—Hypersensitivity—Liotrix—hypothyroidism	0.00151	0.00449	CcSEcCtD
Cladribine—RRM2B—Metabolism—ATP5O—hypothyroidism	0.0015	0.0104	CbGpPWpGaD
Cladribine—DCK—liver—hypothyroidism	0.0015	0.00289	CbGeAlD
Cladribine—ABCG2—adrenal cortex—hypothyroidism	0.00148	0.00286	CbGeAlD
Cladribine—Asthenia—Liotrix—hypothyroidism	0.00147	0.00437	CcSEcCtD
Cladribine—DCK—cerebellum—hypothyroidism	0.00147	0.00283	CbGeAlD
Cladribine—Pruritus—Liotrix—hypothyroidism	0.00145	0.00431	CcSEcCtD
Cladribine—ABCG2—heart—hypothyroidism	0.00144	0.00277	CbGeAlD
Cladribine—RRM2B—Metabolism—TPO—hypothyroidism	0.00141	0.00974	CbGpPWpGaD
Cladribine—Diarrhoea—Liotrix—hypothyroidism	0.0014	0.00417	CcSEcCtD
Cladribine—NR5A1—Developmental Biology—CLTC—hypothyroidism	0.00138	0.00949	CbGpPWpGaD
Cladribine—Dizziness—Liotrix—hypothyroidism	0.00135	0.00403	CcSEcCtD
Cladribine—SLC28A3—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.00133	0.00913	CbGpPWpGaD
Cladribine—PNP—Metabolism—ATP5O—hypothyroidism	0.0013	0.00898	CbGpPWpGaD
Cladribine—Vomiting—Liotrix—hypothyroidism	0.0013	0.00387	CcSEcCtD
Cladribine—Rash—Liotrix—hypothyroidism	0.00129	0.00384	CcSEcCtD
Cladribine—Dermatitis—Liotrix—hypothyroidism	0.00129	0.00384	CcSEcCtD
Cladribine—Headache—Liotrix—hypothyroidism	0.00128	0.00382	CcSEcCtD
Cladribine—SLC22A1—liver—hypothyroidism	0.00128	0.00247	CbGeAlD
Cladribine—SLC28A3—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.00126	0.00867	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—THRA—hypothyroidism	0.00125	0.00859	CbGpPWpGaD
Cladribine—PNP—Metabolism—TPO—hypothyroidism	0.00123	0.00845	CbGpPWpGaD
Cladribine—Nausea—Liotrix—hypothyroidism	0.00122	0.00362	CcSEcCtD
Cladribine—ABCG2—pituitary gland—hypothyroidism	0.0012	0.00231	CbGeAlD
Cladribine—ABCG2—adrenal gland—hypothyroidism	0.00107	0.00206	CbGeAlD
Cladribine—ABCG2—blood—hypothyroidism	0.00107	0.00206	CbGeAlD
Cladribine—ABCG2—thyroid gland—hypothyroidism	0.00103	0.00199	CbGeAlD
Cladribine—ABCG2—female gonad—hypothyroidism	0.000999	0.00192	CbGeAlD
Cladribine—SLC28A3—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000991	0.00682	CbGpPWpGaD
Cladribine—SLC22A2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000965	0.00664	CbGpPWpGaD
Cladribine—SLC22A1—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000899	0.00619	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—NKX2-5—hypothyroidism	0.000889	0.00612	CbGpPWpGaD
Cladribine—ABCG2—testis—hypothyroidism	0.000886	0.00171	CbGeAlD
Cladribine—RRM1—Metabolism—IYD—hypothyroidism	0.000881	0.00607	CbGpPWpGaD
Cladribine—ABCG2—liver—hypothyroidism	0.000838	0.00161	CbGeAlD
Cladribine—ABCG2—cerebellum—hypothyroidism	0.000818	0.00158	CbGeAlD
Cladribine—NR5A1—Gene Expression—THRB—hypothyroidism	0.000804	0.00553	CbGpPWpGaD
Cladribine—SLC22A2—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000782	0.00539	CbGpPWpGaD
Cladribine—RRM1—Metabolism—ATP5O—hypothyroidism	0.000749	0.00516	CbGpPWpGaD
Cladribine—SLC22A2—Neuronal System—SLC5A7—hypothyroidism	0.000739	0.00509	CbGpPWpGaD
Cladribine—SLC22A1—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000729	0.00502	CbGpPWpGaD
Cladribine—RRM2—Metabolism—IYD—hypothyroidism	0.000726	0.005	CbGpPWpGaD
Cladribine—RRM1—Metabolism—TPO—hypothyroidism	0.000705	0.00485	CbGpPWpGaD
Cladribine—SLC22A1—Neuronal System—SLC5A7—hypothyroidism	0.000689	0.00475	CbGpPWpGaD
Cladribine—DCK—Metabolism—IYD—hypothyroidism	0.000678	0.00467	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000661	0.00455	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—TSHB—hypothyroidism	0.000655	0.00451	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—VAV3—hypothyroidism	0.000649	0.00447	CbGpPWpGaD
Cladribine—SLC22A2—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000648	0.00446	CbGpPWpGaD
Cladribine—SLC28A3—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000639	0.0044	CbGpPWpGaD
Cladribine—SLC22A2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000622	0.00428	CbGpPWpGaD
Cladribine—RRM2—Metabolism—ATP5O—hypothyroidism	0.000617	0.00425	CbGpPWpGaD
Cladribine—SLC22A1—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000604	0.00416	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—PIK3C2A—hypothyroidism	0.000584	0.00402	CbGpPWpGaD
Cladribine—RRM2—Metabolism—TPO—hypothyroidism	0.00058	0.004	CbGpPWpGaD
Cladribine—SLC22A1—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00058	0.00399	CbGpPWpGaD
Cladribine—DCK—Metabolism—ATP5O—hypothyroidism	0.000577	0.00397	CbGpPWpGaD
Cladribine—PNP—Metabolism—TSHB—hypothyroidism	0.000568	0.00391	CbGpPWpGaD
Cladribine—DCK—Metabolism—TPO—hypothyroidism	0.000542	0.00373	CbGpPWpGaD
Cladribine—PNP—Metabolism—PIK3C2A—hypothyroidism	0.000506	0.00349	CbGpPWpGaD
Cladribine—SLC28A3—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000503	0.00347	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—SLC5A5—hypothyroidism	0.00049	0.00338	CbGpPWpGaD
Cladribine—SLC22A2—Neuronal System—NEFL—hypothyroidism	0.000476	0.00328	CbGpPWpGaD
Cladribine—SLC22A1—Neuronal System—NEFL—hypothyroidism	0.000444	0.00306	CbGpPWpGaD
Cladribine—PNP—Metabolism—SLC5A5—hypothyroidism	0.000425	0.00293	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000402	0.00277	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000397	0.00274	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000372	0.00256	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.00037	0.00255	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000333	0.00229	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000329	0.00227	CbGpPWpGaD
Cladribine—RRM1—Metabolism—TSHB—hypothyroidism	0.000326	0.00225	CbGpPWpGaD
Cladribine—SLC22A2—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000313	0.00215	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000307	0.00211	CbGpPWpGaD
Cladribine—SLC22A1—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000291	0.00201	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PIK3C2A—hypothyroidism	0.000291	0.002	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—IYD—hypothyroidism	0.000271	0.00187	CbGpPWpGaD
Cladribine—RRM2—Metabolism—TSHB—hypothyroidism	0.000269	0.00185	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—IYD—hypothyroidism	0.000269	0.00185	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—POMC—hypothyroidism	0.000257	0.00177	CbGpPWpGaD
Cladribine—DCK—Metabolism—TSHB—hypothyroidism	0.000251	0.00173	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—IYD—hypothyroidism	0.00025	0.00172	CbGpPWpGaD
Cladribine—SLC22A2—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000246	0.0017	CbGpPWpGaD
Cladribine—RRM1—Metabolism—SLC5A5—hypothyroidism	0.000244	0.00168	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PIK3C2A—hypothyroidism	0.000239	0.00165	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ATP5O—hypothyroidism	0.000231	0.00159	CbGpPWpGaD
Cladribine—SLC22A1—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000229	0.00158	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ATP5O—hypothyroidism	0.000228	0.00157	CbGpPWpGaD
Cladribine—DCK—Metabolism—PIK3C2A—hypothyroidism	0.000224	0.00154	CbGpPWpGaD
Cladribine—PNP—Metabolism—POMC—hypothyroidism	0.000222	0.00153	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—TPO—hypothyroidism	0.000217	0.00149	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—TPO—hypothyroidism	0.000215	0.00148	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ATP5O—hypothyroidism	0.000213	0.00147	CbGpPWpGaD
Cladribine—RRM2—Metabolism—SLC5A5—hypothyroidism	0.000201	0.00138	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—TPO—hypothyroidism	0.0002	0.00138	CbGpPWpGaD
Cladribine—DCK—Metabolism—SLC5A5—hypothyroidism	0.000188	0.00129	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000161	0.00111	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000159	0.00109	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000148	0.00102	CbGpPWpGaD
Cladribine—RRM1—Metabolism—POMC—hypothyroidism	0.000128	0.00088	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000126	0.00087	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000125	0.000861	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000117	0.000803	CbGpPWpGaD
Cladribine—RRM2—Metabolism—POMC—hypothyroidism	0.000105	0.000724	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—TSHB—hypothyroidism	0.0001	0.000692	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—TSHB—hypothyroidism	9.94e-05	0.000685	CbGpPWpGaD
Cladribine—DCK—Metabolism—POMC—hypothyroidism	9.83e-05	0.000677	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—TSHB—hypothyroidism	9.27e-05	0.000638	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PIK3C2A—hypothyroidism	8.95e-05	0.000617	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PIK3C2A—hypothyroidism	8.86e-05	0.00061	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PIK3C2A—hypothyroidism	8.26e-05	0.000569	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—SLC5A5—hypothyroidism	7.52e-05	0.000518	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—SLC5A5—hypothyroidism	7.44e-05	0.000512	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—SLC5A5—hypothyroidism	6.94e-05	0.000478	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—POMC—hypothyroidism	3.93e-05	0.000271	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—POMC—hypothyroidism	3.89e-05	0.000268	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—POMC—hypothyroidism	3.63e-05	0.00025	CbGpPWpGaD
